205 related articles for article (PubMed ID: 20128686)
1. Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications.
Gabril M; White NM; Moussa M; Chow TF; Metias SM; Fatoohi E; Yousef GM
Biol Chem; 2010 Apr; 391(4):403-9. PubMed ID: 20128686
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.
White NM; Bui A; Mejia-Guerrero S; Chao J; Soosaipillai A; Youssef Y; Mankaruos M; Honey RJ; Stewart R; Pace KT; Sugar L; Diamandis EP; Doré J; Yousef GM
Biol Chem; 2010 Apr; 391(4):411-23. PubMed ID: 20180642
[TBL] [Abstract][Full Text] [Related]
3. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
6. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
Sejima T; Miyagawa I
Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
[TBL] [Abstract][Full Text] [Related]
7. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
10. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
[TBL] [Abstract][Full Text] [Related]
11. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
12. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
[TBL] [Abstract][Full Text] [Related]
13. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
[TBL] [Abstract][Full Text] [Related]
14. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of activator protein-2 isoforms in renal cell carcinoma.
Oya M; Mikami S; Mizuno R; Miyajima A; Horiguchi Y; Nakashima J; Marumo K; Mukai M; Murai M
Urology; 2004 Jul; 64(1):162-7. PubMed ID: 15245963
[TBL] [Abstract][Full Text] [Related]
16. [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips].
Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G
Verh Dtsch Ges Pathol; 1999; 83():225-32. PubMed ID: 10714215
[TBL] [Abstract][Full Text] [Related]
17. Expression of S-100 protein in renal cell neoplasms.
Lin F; Yang W; Betten M; Teh BT; Yang XJ;
Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922
[TBL] [Abstract][Full Text] [Related]
18. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma.
Yusenko MV; Kovacs G
Histopathology; 2009 Dec; 55(6):687-95. PubMed ID: 20002769
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
20. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
